$BSPK
Bespoke Extracts, Inc. Stock $bspk

$bspk Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000121390024033935 Filed on April 18, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$263.8K	$785.5K	$3.407K
YoY Change		22954.09%	-26.73%
Cost Of Revenue	$100.4K	$442.3K	$1.149K
YoY Change	-316.26%	38393.39%	-44.49%
Gross Profit	$163.4K	$343.2K	$2.258K
YoY Change	251.86%	15097.7%	-12.48%
Gross Profit Margin	61.93%	43.69%	66.28%
Selling, General & Admin	$428.3K	$1.587M	$3.742M
YoY Change	-54.8%	-57.6%	1059.32%
% of Gross Profit	262.16%	462.36%	165734.06%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.790K	$8.968K	$0.00
YoY Change
% of Gross Profit	1.1%	2.61%	0.0%
Operating Expenses	$428.3K	$1.815M	$4.023M
YoY Change	-54.8%	-54.88%	1146.26%
Operating Profit	-$264.9K	-$1.472M	-$4.021M
YoY Change	-70.6%	-63.39%	1155.59%
Interest Expense	-$4.170K	-$10.87K	$197.00
YoY Change	-1768.0%	-5617.77%
% of Operating Profit
Other Income/Expense, Net		-$10.87K	-$95.57K
YoY Change		-88.63%
Pretax Income	-$269.1K	-$1.483M	-$4.116M
YoY Change	-73.03%	-63.98%	16163.24%
Income Tax
% Of Pretax Income
Net Earnings	-$269.1K	-$1.483M	-$4.116M
YoY Change	-73.03%	-63.98%	16163.24%
Net Earnings / Revenue	-102.01%	-188.79%	-120816.76%
Basic Earnings Per Share		-$0.15	-$0.44
Diluted Earnings Per Share	-$0.03	-$0.15	-$0.44
COMMON SHARES
Basic Shares Outstanding		10.17M shares	9.367M shares
Diluted Shares Outstanding		10.17M shares	9.367M shares

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.610K	$6.610K	$24.43K
YoY Change	-72.94%	-72.94%	-83.52%
Cash & Equivalents	$6.607K
Short-Term Investments
Other Short-Term Assets	$14.21K	$14.21K	$87.30K
YoY Change	-83.72%	-83.72%	1255.59%
Inventory	$15.80K	$15.80K	$0.00
Prepaid Expenses	$5.000K
Receivables	$45.23K	$45.23K	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$81.84K	$81.84K	$111.7K
YoY Change	-26.75%	-26.75%	-45.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$40.98K	$250.5K	$285.9K
YoY Change	311.97%	-12.36%	-16.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$12.00K	$12.00K	$12.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$272.5K	$272.5K	$297.9K
YoY Change	-8.51%	-8.51%	-15.98%
TOTAL ASSETS
Total Short-Term Assets	$81.84K	$81.84K	$111.7K
Total Long-Term Assets	$272.5K	$272.5K	$297.9K
Total Assets	$354.4K	$354.4K	$409.6K
YoY Change	-13.48%	-13.48%	-26.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$961.3K	$961.3K	$295.8K
YoY Change	224.95%	224.95%	257.57%
Accrued Expenses	$64.33K	$64.33K	$64.33K
YoY Change	0.0%	0.0%	7.61%
Deferred Revenue
YoY Change
Short-Term Debt	$53.37K	$53.37K	$415.5K
YoY Change	-87.16%	-87.16%	16520.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.079M	$1.079M	$865.7K
YoY Change	24.64%	24.64%	293.46%
LONG-TERM LIABILITIES
Long-Term Debt	$849.5K	$849.5K	$0.00
YoY Change
Other Long-Term Liabilities	$150.5K	$150.5K	$216.0K
YoY Change	-30.36%	-30.36%	-22.94%
Total Long-Term Liabilities	$1.000M	$1.000M	$216.0K
YoY Change	362.86%	362.86%	-22.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.079M	$1.079M	$865.7K
Total Long-Term Liabilities	$1.000M	$1.000M	$216.0K
Total Liabilities	$2.079M	$2.079M	$1.082M
YoY Change	92.19%	92.19%	116.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.37M
YoY Change	6.21%
Common Stock	$10.17K
YoY Change	2.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.725M	-$1.725M	-$672.1K
YoY Change
Total Liabilities & Shareholders Equity	$354.4K	$354.4K	$409.6K
YoY Change	-13.48%	-13.48%	-26.81%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	-$269.1K	-$1.483M	-$4.116M
YoY Change	-73.03%	-63.98%	16163.24%
Depreciation, Depletion And Amortization	$1.790K	$8.968K	$0.00
YoY Change
Cash From Operating Activities	-$19.77K	-$415.2K	-$798.1K
YoY Change	-89.78%	-47.97%	656.82%
INVESTING ACTIVITIES
Capital Expenditures			$7.202K
YoY Change
Acquisitions
YoY Change
Other Investing Activities			-$80.77K
YoY Change
Cash From Investing Activities			-$87.97K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$344.5K
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	26.37K	$397.4K	$762.2K
YoY Change	-89.68%	-47.87%	214.33%
NET CHANGE
Cash From Operating Activities	-19.77K	-$415.2K	-$798.1K
Cash From Investing Activities			-$87.97K
Cash From Financing Activities	26.37K	$397.4K	$762.2K
Net Change In Cash	6.600K	-$17.83K	-$123.8K
YoY Change	-51.36%	-85.6%	-190.33%
FREE CASH FLOW
Cash From Operating Activities	-$19.77K	-$415.2K	-$798.1K
Capital Expenditures			$7.202K
Free Cash Flow		-$415.2K	-$805.3K
YoY Change		-48.44%	663.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9367458	shares
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
CY2022Q4	bspk	License License		usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-52759
CY2023	dei	Entity Registrant Name EntityRegistrantName	BESPOKE EXTRACTS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-4743354
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	12001 E. 33rd Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Unit O
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Aurora
CY2023	dei	Entity Address Country EntityAddressCountry	CO
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80010
CY2023	dei	City Area Code CityAreaCode	(720)
CY2023	dei	Local Phone Number LocalPhoneNumber	949-1143
CY2023	dei	Security12g Title Security12gTitle	Common Stock, par value $0.001 per share
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1300000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10168552	shares
CY2023	dei	Auditor Name AuditorName	ASSURANCE DIMENSIONS
CY2023	dei	Auditor Location AuditorLocation	Margate, Florida
CY2023	dei	Auditor Firm AuditorFirmId	5036
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6607	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24433	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45226	usd
CY2023Q4	bspk	Prepaid Stock Awards PrepaidStockAwards	9206	usd
CY2022Q4	bspk	Prepaid Stock Awards PrepaidStockAwards	80113	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7186	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	15800	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	81839	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	111732	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	40979	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	9947	usd
CY2023Q4	bspk	License License	10000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	209542	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	275912	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	12000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	12000	usd
CY2023Q4	us-gaap	Assets Assets	354360	usd
CY2022Q4	us-gaap	Assets Assets	409591	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	961255	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	295818	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	90000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64330	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64330	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1078957	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	865648	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	849500	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	150460	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	216039	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2078917	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1081687	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10168552	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10168552	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9945997	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9945997	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	10166	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	9944	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23631918	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23201758	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25366641	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23883798	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1724557	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-672096	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	354360	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	409591	usd
CY2023	us-gaap	Revenues Revenues	785453	usd
CY2022	us-gaap	Revenues Revenues	3407	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	442289	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1149	usd
CY2023	us-gaap	Gross Profit GrossProfit	343164	usd
CY2022	us-gaap	Gross Profit GrossProfit	2258	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1586666	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3742275	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	192476	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	155888	usd
CY2023	bspk	Consulting Fees ConsultingFees	36000	usd
CY2022	bspk	Consulting Fees ConsultingFees	124750	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1815142	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	4022913	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1471978	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4020655	usd
CY2023	bspk	Investment Income Investment Expenses InvestmentIncomeInvestmentExpenses	10865	usd
CY2022	bspk	Investment Income Investment Expenses InvestmentIncomeInvestmentExpenses	-197	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	931	usd
CY2022	bspk	Earnout Expense EarnoutExpense	-15000	usd
CY2022	bspk	Allowance For Notes And Advances AllowanceForNotesAndAdvances	-45931	usd
CY2022	bspk	Reserve For Advances To Wonder Leaf ReserveForAdvancesToWonderLeaf	-35769	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10865	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-95572	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1482843	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4116227	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1482843	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4116227	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10168552	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9367458	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1989961	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	4793	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1104927	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	344450	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4116227	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-672096	usd
CY2023	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	50000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	380382	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1482843	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1724557	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1482843	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4116227	usd
CY2023	bspk	Inventory Reserve InventoryReserve	40393	usd
CY2023	us-gaap	Depreciation Depreciation	8968	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3636	usd
CY2022	bspk	Reserve For Notes Receivable And Advances ReserveForNotesReceivableAndAdvances	46825	usd
CY2022	bspk	Interest Receivables InterestReceivables	81700	usd
CY2023	bspk	Amortization Of Right Of Use Asset Net AmortizationOfRightOfUseAssetNet	66370	usd
CY2022	bspk	Amortization Of Right Of Use Asset Net AmortizationOfRightOfUseAssetNet	-931	usd
CY2023	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	70907	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	380382	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2955500	usd
CY2022	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	15000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	45226	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2186	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	747	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	56193	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	665437	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	213086	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-65579	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	4091	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-415198	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-798067	usd
CY2022	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	35769	usd
CY2022	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	45000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7202	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-87971	usd
CY2022	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	4793	usd
CY2023	bspk	Payment Of Inventory Earnout PaymentOfInventoryEarnout	90000	usd
CY2023	bspk	Proceeds From Issuance Of Note Payable Related Party ProceedsFromIssuanceOfNotePayableRelatedParty	434000	usd
CY2022	bspk	Proceeds From Issuance Of Note Payable Related Party ProceedsFromIssuanceOfNotePayableRelatedParty	415500	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	53372	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2500	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	344450	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	397372	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	762243	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-17826	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-123795	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24433	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	148228	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6607	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24433	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	50000	usd
CY2022	bspk	Stock Issued For Prepaid Consulting StockIssuedForPrepaidConsulting	116499	usd
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	222223	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	50000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.225
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-415198	usd
CY2023	bspk	Working Capital Deficit WorkingCapitalDeficit	997118	usd
CY2023Q4	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	25366641	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates. </p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	15800	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	15800	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	76392	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	4200	usd
CY2023	us-gaap	Lease Cost LeaseCost	60444	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1689837	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1443258	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	7293000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	6277000	usd
CY2023Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	222223	shares
CY2023Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	50000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.225
CY2023Q4	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	50000	usd
CY2023Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	222223	shares
CY2023	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	50000	usd
CY2023	us-gaap	Taxes And Licenses TaxesAndLicenses	10000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	40000	usd
CY2022Q3	bspk	Operating Profit Sale Percentage OperatingProfitSalePercentage	0.40	pure
CY2022Q3	bspk	Inventory Earn Out InventoryEarnOut	75000	usd
CY2022Q4	bspk	Inventory Earn Out InventoryEarnOut	90000	usd
CY2022Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	10000	usd
CY2022Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	10000	usd
CY2022Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	25000	usd
CY2022	us-gaap	Financing Receivable Accrued Interest Writeoff FinancingReceivableAccruedInterestWriteoff	931	usd
CY2022	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	45931	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	76372	usd
CY2022	us-gaap	Lease Cost LeaseCost	80572	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M2D
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49947	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9947	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8968	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40979	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9947	usd
CY2023	us-gaap	Depreciation Depreciation	8968	usd
CY2023Q4	us-gaap	Securities Loaned SecuritiesLoaned	469954	usd
CY2023Q3	us-gaap	Other Notes Payable OtherNotesPayable	849500	usd
CY2023Q3	us-gaap	Percentage Of Interest Bearing Domestic Deposits To Deposits PercentageOfInterestBearingDomesticDepositsToDeposits	0.05	pure
CY2023Q4	bspk	Net Proceeds NetProceeds	2000000	usd
CY2023Q4	bspk	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	902872	usd
CY2022Q4	bspk	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	415500	usd
CY2023Q4	us-gaap	Customer Advances Noncurrent CustomerAdvancesNoncurrent	53372	usd
CY2023Q4	us-gaap	Lessee Finance Lease Remaining Lease Term LesseeFinanceLeaseRemainingLeaseTerm	P5Y
CY2023Q4	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P5Y
CY2023	us-gaap	Payments For Rent PaymentsForRent	6000	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	600000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M8D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	75915	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	79380	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	72765	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	228060	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13090	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	214970	usd
CY2023	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	45-to-1
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	222223	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	50000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.225
CY2022	bspk	Shares Issued To Investors SharesIssuedToInvestors	1530897	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1530897	shares
CY2022	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	344450	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2023-06-30
CY2023Q2	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	2.25
CY2022Q3	bspk	Shares Of Common Stock SharesOfCommonStock	266667	shares
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	155556	shares
CY2022	us-gaap	Other Expenses OtherExpenses	1104928	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	70907	usd
CY2023	us-gaap	Restricted Stock Award Forfeitures RestrictedStockAwardForfeitures	9206	usd
CY2022	us-gaap	Restricted Stock Award Forfeitures RestrictedStockAwardForfeitures	80113	usd
	bspk	Shares Issued To Investors SharesIssuedToInvestors	50000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	12500000	shares
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	250000	usd
	us-gaap	Legal Fees LegalFees	10000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P1Y
	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	2.25
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2023	bspk	Earnout Expense EarnoutExpense		usd
CY2023	bspk	Allowance For Notes And Advances AllowanceForNotesAndAdvances		usd
CY2023	us-gaap	Fair Value Option Credit Risk Gains Losses On Assets FairValueOptionCreditRiskGainsLossesOnAssets	900000	usd
CY2021Q4	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	22222	shares
CY2021Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1.35
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	30000	usd
CY2023Q3	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	222500	shares
CY2023Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.2
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	44306	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	15056	usd
CY2023	us-gaap	Present Value Of Future Insurance Profits Amortization Expense1 PresentValueOfFutureInsuranceProfitsAmortizationExpense1	172752	usd
CY2023Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	487372	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	902872	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	415500	usd
CY2023Q3	us-gaap	Other Notes Payable OtherNotesPayable	849500	usd
CY2023Q3	us-gaap	Percentage Of Interest Bearing Domestic Deposits To Deposits PercentageOfInterestBearingDomesticDepositsToDeposits	0.05	pure
CY2023	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	2000000	usd
CY2023Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	206772	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	156944	usd
CY2021Q3	bspk	Principal Amounts PrincipalAmounts	400000	usd
CY2022Q3	bspk	Operating Profit Percentage OperatingProfitPercentage	0.40	pure
CY2022Q4	us-gaap	Progress Payments Netted Against Inventory For Long Term Contracts Or Programs ProgressPaymentsNettedAgainstInventoryForLongTermContractsOrPrograms	90000	usd
CY2021Q4	bspk	Executive Officer Salary ExecutiveOfficerSalary	8000	usd
CY2021Q4	bspk	Stock Issued During Period Shares Others StockIssuedDuringPeriodSharesOthers	666667	shares
CY2021Q4	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	0.06
CY2021Q4	bspk	Premium Percentage PremiumPercentage	1.20	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	bspk	Effective Income Tax Rate Permanent Differences EffectiveIncomeTaxRatePermanentDifferences	0.0352	pure
CY2022	bspk	Effective Income Tax Rate Permanent Differences EffectiveIncomeTaxRatePermanentDifferences	0.0028	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2452	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2472	pure
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	21179	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	21179	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	41079	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	21045	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1650169	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1401034	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1712427	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1443258	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1712427	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1443258	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	363620	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1009374	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	94451	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	756935	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	269170	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	252756	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023	bspk	Reserve For Advances To Wonder Leaf ReserveForAdvancesToWonderLeaf		usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10168552	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022	bspk	Inventory Reserve InventoryReserve		usd
CY2022	us-gaap	Depreciation Depreciation		usd
CY2023	bspk	Reserve For Notes Receivable And Advances ReserveForNotesReceivableAndAdvances		usd
CY2023	bspk	Interest Receivables InterestReceivables		usd
CY2022	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges		usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2023	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate		usd
CY2023	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties		usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2022	bspk	Payment Of Inventory Earnout PaymentOfInventoryEarnout		usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2023	bspk	Stock Issued For Prepaid Consulting StockIssuedForPrepaidConsulting		usd
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		usd
CY2022	us-gaap	Depreciation Depreciation		usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate		pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent		pure
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001409197
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true

Files In Submission

Name	View Source	Status
0001213900-24-033935-index-headers.html	Edgar Link	pending
0001213900-24-033935-index.html	Edgar Link	pending
0001213900-24-033935.txt	Edgar Link	pending
0001213900-24-033935-xbrl.zip	Edgar Link	pending
bspk-20231231.xsd	Edgar Link	pending
ea0202767-10k_bespoke.htm	Edgar Link	pending
bspk-20231231_cal.xml	Edgar Link	unprocessable
bspk-20231231_def.xml	Edgar Link	unprocessable
bspk-20231231_lab.xml	Edgar Link	unprocessable
bspk-20231231_pre.xml	Edgar Link	unprocessable
ea020276701ex21-1_bespoke.htm	Edgar Link	pending
ea020276701ex31-1_bespoke.htm	Edgar Link	pending
ea020276701ex32-1_bespoke.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ea0202767-10k_bespoke_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BSPK
Bespoke Extracts, Inc. Stock $bspk

2023 Q4 Form 10-K Financial Statement

#000121390024033935 Filed on April 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BSPK Bespoke Extracts, Inc. Stock $bspk

2023 Q4 Form 10-K Financial Statement

#000121390024033935 Filed on April 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BSPK
Bespoke Extracts, Inc. Stock $bspk